Invivyd (IVVD) Change in Inventory (2024 - 2025)

Invivyd (IVVD) posted Change in Inventory of $352000.0 for Q4 2025, up 804.0% on a QoQ basis from -$50000.0 in Q3 2025, and down 76.5% year-over-year from $1.5 million in Q4 2024.

Invivyd (IVVD) Change in Inventory (2024 - 2025) Analysis & Trends

Invivyd's Change in Inventory history runs 2 years deep, the most recent figure standing at $352000.0 for Q4 2025.

  • Quarterly Change in Inventory fell 76.5% year-over-year to $352000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $373000.0 (down 98.5% YoY) and the FY2025 annual result came in at $373000.0, down 98.5% from the prior year.
  • Change in Inventory was $352000.0 for Q4 2025 at Invivyd, up from -$50000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $20.8 million in Q3 2024 and bottomed at -$50000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn - -
2 Nanobiotix 1,909.44 Bn 1,909.38 Bn - -
3 Akari Therapeutics 989.71 Bn 989.71 Bn - -
4 BeOne Medicines 471.58 Bn 466.79 Bn 1.35 Bn 71.84 Mn
5 Vertex Pharmaceuticals 121.97 Bn 114.72 Bn 2.59 Bn 97.70 Mn
6 Regeneron Pharmaceuticals 69.93 Bn 61.18 Bn 3.31 Bn -26.60 Mn
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.80 Bn 50.61 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.37 Bn 34.36 Bn 959.66 Mn 3.32 Mn
10 Invivyd 104.45 Mn -122.24 Mn 16.07 Mn 352,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 352,000.00
Dec 31, 2025 352,000.00
Sep 30, 2025 -50,000.00
Sep 30, 2025 -50,000.00
Jun 30, 2025 13,000.00
Jun 30, 2025 13,000.00
Mar 31, 2025 58,000.00
Mar 31, 2025 58,000.00
Dec 31, 2024 1.50 Mn
Dec 31, 2024 1.50 Mn
Sep 30, 2024 20.76 Mn
Sep 30, 2024 20.76 Mn
Jun 30, 2024 2.53 Mn
Jun 30, 2024 2.53 Mn
Mar 31, 2024 104,000.00
Mar 31, 2024 104,000.00